With the Phase III trials looming, the results of Dr. Pridgen’s phase II clinical trials on his antiviral approach to fibromyalgia have been released.
His next step – finding a way through the “valley of death” where many drug possibilities go to die – and launch the Phase III trials needed for the FDA drug approval. Find out what Dr. Pridgen thought of the last trial and how he’s getting ready for the next in a Simmaron Research Foundation sponsored blog…
Print Friendly, PDF & Email

Don't Miss Another Blog!

Like this blog?

Make sure you don’t miss another  one by registering for our free ME/CFS and Fibromyalgia blogs here..

Pin It on Pinterest

Share This